Robert Sanders

Researchers at UC Berkeley and UCSF evaluated the reliability and accuracy of 12 COVID-19 test kits in response to the need for accessible and dependable testing.

After four years of litigation battles, the US Patent and Trademark Office, or USPTO, has finally approved a third CRISPR patent for the University of California.

Claiming 524 utility patents for 2017, the ten UC campuses have continuously held first place by a margin more than 100 utility patents since the NAI’s first ranking in 2013.

China’s State Intellectual Property Office, or SIPO, announced Monday that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology.

The Intellectual Property and Science division of Thomson Reuters has named UC Berkeley chemistry and molecular and cell biology professor Jennifer Doudna as a citation laureate for her development of the CRISPR-Cas9 genome-editing method.

For more than 30 years, UC Berkeley has been at the forefront of GMO research and development. Many faculty members have been divided between work to bring genetically modified products to the marketplace and attempts to challenge their dispersal in the environment.